Recent Articles from Business Wire

Last night, Boys & Girls Clubs of America named Enrique R. L. from Boys & Girls Clubs of Saint Lucie County its 2026–2027 National Youth of the Year in a celebration held at Cipriani in New York City. The event, emceed by Sara Haines of ABC’s The View, honored six extraordinary teens from across the country for their outstanding leadership, service, academic excellence, and dedication to health and wellbeing.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) and reminds investors of the October 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

AM Best was named “Rating Agency of the Year” at the Insurance Insider US Honors event on Sept. 30, 2026, in New York City. Accepting the award was James Gillard, president of AM Best Rating Services.

California Pizza Kitchen (CPK), the iconic restaurant brand that revolutionized pizza, is making amends with its fan base this National Pizza Month for failing to bring back all the beloved pizzas from its past menus. Responding to years of guest requests and social comments clamoring for the comeback of pizzas like Jamaican Jerk Chicken, Shrimp Scampi, or Pear and Gorgonzola – the brand is humorously offering a two-part appeasement to its guests. First, up to 25,000 so-called “Apology Pizzas” will be available to claim through the end of the month, followed by a promise to bring one fan-favorite pizza back to the menu in 2027.

EMCOR Group, Inc. (NYSE: EME) today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per common share. The dividend will be paid on October 30, 2026 to stockholders of record as of October 15, 2026.

Watkins, LLC ("The Watkins Company") today announced it has completed its acquisition of the Sauer Brands, Inc. (“Sauer Brands”) spice business. The combination brings together two businesses with roots in flavor dating to the 1800s, creating a flavor company with a broader portfolio, deeper manufacturing capabilities and the scale to help serve consumers wherever and however they experience flavor.

Versant (Nasdaq: VSNT) today announced it has reached a multi-year renewal of their distribution agreement with Verizon. The long-term agreement will continue to make Versant’s portfolio of iconic brands, including USA Network, MS NOW, CNBC, Oxygen True Crime, Golf Channel, E!, and SYFY available to Verizon customers.

CJ CheilJedang (CJ, KRX: 097950), a global food and biotech company that owns a leading animal nutrition business (known as CJ Bio), and ADM (NYSE: ADM), a global leader in innovative solutions from nature, have agreed to form a new joint venture to secure a reliable, long-term source of feed-grade amino acids critical to the livestock industry, strengthening U.S. production, global supply chain resilience and U.S. food security.

AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “a-” (Excellent) of Enact Re Ltd. (ERL) (Bermuda). The outlook of these Credit Ratings (ratings) is stable.

Cable One, Inc. (NYSE: CABO) (“Cable One” or the “Company”) today announced it is in advanced discussions with GTCR LLC (“GTCR”), certain of its existing lenders and a consortium of leading private lending institutions regarding financing transactions to address certain of the Company’s forthcoming capital needs. Cable One is working towards enhancing its capital structure to position the company to drive growth in shareholder value.

In the third quarter, we produced over 464,000 vehicles, delivered over 486,000 vehicles and deployed 13.7 GWh of energy storage products.

Obsidian Therapeutics, Inc. (“Obsidian”) (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced a poster presentation of updated data in patients with immune-checkpoint inhibitor (ICI)-resistant advanced melanoma from the Phase 1 single-center first-in-human (FIH) study and the Phase 1/2 Agni-01 multicenter study of amsokigene autoleucel (amsoki-cel, formerly OBX-115), an engineered TIL cell therapy armored with pharmacologically regulatable membrane-bound IL15 (mbIL15), at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, taking place in Phoenix, AZ, November 4-8, 2026. The poster presentation will summarize pooled safety data across the FIH study and the Phase 1/2 Agni-01 multicenter study, and an efficacy update from Agni-01 patients treated at the recommended phase 2 dose (n=15).

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today announced that two presentations of new data from its ongoing Phase 1/2 study of imneskibart will be featured at the Society for Immunotherapy of Cancer (SITC) Annual Meeting.

Singleton Associates, P.A. (Singleton Associates), a Radiology Partners-affiliated practice, and Blue Cross and Blue Shield of Texas (BCBSTX) have reached a new multi-year agreement, effective November 1, 2026.

SharkNinja, Inc. (NYSE: SN), a leading global product design and technology company, today announced the launch of the Ninja PREPi™ Precision-Powered Prep + Store System. The compact system tackles time-consuming dicing, chopping, slicing, shredding, puréeing and even crinkling — all in a single bowl that goes from prep to table to fridge to out the door in no time.

Marsh (NYSE:MRSH), a leading global professional services firm, today announced the completion of its previously announced agreement to acquire Accel Holdings, Inc, a leading diversified independent insurance and advisory firm headquartered in Waverly, Iowa. Accel will operate within Marsh Agency. Terms of the acquisition were not disclosed.

ReSource Pro, a strategic operations and technology services partner to the insurance industry, today launched ProTalks, a new series giving insurance leaders practical insight into the operational and technology decisions they are making now — from AI and data modernization to M&A integration, workforce transformation and regulatory change.

Most attorneys study trucking cases from behind a desk. DM Injury Law attorney Ryan Watson decided to study them from behind the wheel. Watson has completed Kingdom Trucking Academy and earned his Missouri Class A Commercial Driver's License (CDL), giving him firsthand knowledge of the training, regulations, inspections, and daily safety responsibilities required of commercial truck drivers.

Pheast Therapeutics, a clinical-stage biotechnology company advancing next-generation targeted therapies for cancer, today announced an upcoming poster presentation of preclinical data on PHST001 at the 41st Society for Immunotherapy of Cancer (SITC) Annual Meeting, taking place from November 4-8 in Phoenix, AZ. PHST001 is a first-in-class anti-CD24 macrophage checkpoint inhibitor designed to restore immune recognition in the tumor microenvironment and is currently being evaluated in a Phase 1 clinical trial in patients with solid tumors, including ovarian cancer.

SeatGeek, the technology company that has put data at the center of the live event experience from day one, today announced the launch of TourIQ, a predictive intelligence product built for the people who book and price live shows. TourIQ tells a promoter or venue what a concert or third party event is worth at any building, for any artist, on any date, before a single ticket is sold, then generates a price for every seat in the house so the show opens with the right scaling from day one.

Catalyst Opportunity Funds (Catalyst), a private equity firm focused on affordable and workforce housing, and Kōz Development announced today the delivery of Kōz on West 5th, a 210-unit workforce housing development in downtown Spokane. The project, which delivered in September 2026, is the largest development to leverage Washington State's Parking to People incentive — a program that exempts developers from sales tax on materials and labor in exchange for building on underused parking lots and ensuring that at least 50% of units remain affordable.

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally.

John Marshall Bancorp, Inc. (Nasdaq: JMSB) today announced that it expects to issue third quarter 2026 earnings before the market opens on Wednesday, October 28, 2026.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that two posters highlighting research on botensilimab (BOT), an Fc-enhanced multifunctional anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, taking place November 4-8, 2026, in Phoenix, Arizona.

ValGenesis Inc., the leader in enterprise digital validation, will explore real-world insights into the practical application of AI-assisted validation at KENX Europe 2026: Harnessing the Power of AI in GxP, taking place Oct. 14–15, 2026, at the Four Elements Hotel Amsterdam in Amsterdam, the Netherlands.

Astroport Space Technologies, Inc. (“Astroport”), a premier provider of autonomous lunar construction solutions and in-situ materials manufacturing technologies, today announced that it has received a Phase II-E award from NASA’s Small Business Innovation Research (SBIR/STTR) program to accelerate development of its lunar surface infrastructure and extreme-environment civil engineering technologies. The award’s matching-funds requirement has been met through a strategic equity investment from Knight Aerospace (“Knight”), a global leader in specialized airborne modular systems and cargo palletization.

Velour Beauty, the leaders in false lashes, today announced the launch of “Velour x Spencer Self-Stick Lash Cluster Kits”, a collaborative product with world-renowned makeup artist and beauty influencer, Spencer Hedges. This collaboration product marks the first self-stick lash cluster on the market designed specifically for the wet-lash look.

The Delaware Court of Chancery has ruled in favor of Dometic Corp., finding that the company did not breach the agreement underlying its acquisition of cooler manufacturer Igloo, and declined to award ACON Igloo Holdings, LLC, any damages, let alone the $127 million sought by ACON at trial.

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will introduce Easy Order at the 2026 American Academy of Pediatrics (AAP) National Conference & Exhibition, October 2-6 in San Diego. The new streamlined experience makes it faster and simpler for general pediatricians to order ExomeDx™ and chromosomal microarray (CMA) and is part of GeneDx’s broader effort to simplify genomic testing from ordering through understanding and communicating results.

Rivian Automotive, Inc. (NASDAQ: RIVN) today announced production and delivery totals for the quarter ending September 30, 2026. The company produced 19,751 vehicles at its manufacturing facility in Normal, Illinois and delivered 19,248 vehicles during the same period.

The New Jersey Devils announced today a multi-year expansion of their longstanding partnership with Prudential Financial Inc., designating Prudential as the club’s first-ever away jersey patch partner and PGIM, Prudential’s $1.5 trillion global asset management business*, as the team’s away helmet decal partner. The expanded partnership further strengthens Prudential’s ties to its headquarters city of Newark through community initiatives such as the Raise Jersey program, in which Prudential will serve as presenting partner, and extended support for Military Appreciation Night initiatives.

Rithm Capital Corp. (NYSE: RITM) (“Rithm”), a global alternative asset manager, today announced the closing of a joint venture with a fund managed by DRA Advisors LLC (“DRA”) for the ownership of 1301 Avenue of the Americas, one of the flagship assets in the New York City office portfolio of Elecor Properties (“Elecor”), Rithm’s real estate operating platform. Rithm, through Elecor, will continue to hold majority ownership of the asset and operate the building on behalf of the joint venture. Terms of the transaction are not being disclosed.

Autonomous Power Corporation, dba Powerus (“Powerus”), a U.S. defense technology company focused on autonomous and unmanned systems, today announced that it has completed its previously announced merger with Aureus Greenway Holdings Inc. (Nasdaq: PUSA) (“AGH”), effective October 1, 2026.

Proposed changes to the federal terrorism insurance backstop could increase the trigger to $10 million from $5 million and require insurers to take on more terrorism losses, according to new AM Best commentary.

Sparta® Medicinal Wild Olive Oil®, an officially licensed Medicinal Olive Oil® since 2018, stuns with an unprecedented 5134 mg/kg of total polyphenols, a new world record for polyphenol concentration in olive oil for the 2026–2027 harvest.

Newell Brands Inc. (NASDAQ: NWL) today announced its third quarter 2026 earnings results will be released Friday, October 30, 2026 prior to market open and will be followed by a live webcast at 7:30 a.m. ET. To listen to the webcast, please select Events & Presentations from the Investors tab of the Newell Brands website at www.newellbrands.com. The live webcast will be recorded and made available for replay.

Freeport (NYSE: FCX) today provided an update on its third-quarter 2026 operating results.

Bally’s Corporation (NYSE: BALY) (“Bally’s” or the “Company”) announced today that it closed the previously announced financing led by WhiteHawk Capital Partners, LP. The Company received initial funding of term loans in an aggregate principal amount of $400 million, the proceeds of which will be used to pay certain pre-construction costs and expenditures associated with the development of the Bally’s Bronx project, with a portion applied to general corporate purposes, including payment of transaction fees and expenses incurred at closing. Additional delayed draw term loan commitments in an aggregate amount of $160 million remain available for future draws to support the continued development of the Bally’s Bronx project.

Global Industrial Company (NYSE: GIC), a value-added national distributor and source for industrial equipment and supplies, concluded its 2026 National Trade Show, held September 30–October 1 at the Gaylord Texan Resort & Convention Center in Grapevine, Texas.

Vontier (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, will showcase its vision for the future of connected convenience retail at the upcoming National Association of Convenience Stores (NACS) Trade Show in Las Vegas, October 7-9 (Booth #C6623).

Orano Med, a subsidiary of the Orano group and pioneer in the field of targeted alpha therapies for oncology, today announced the inauguration of its ATLab (Alpha Therapy Laboratory) Valenciennes, Europe’s first industrial-scale pharmaceutical facility dedicated to the production of lead-212-based radioligand therapies. The opening ceremony took place in Onnaing, France, in the presence of Claude Imauven, Chairman of the Board of Directors of Orano, Nicolas Maes, CEO of Orano, Frederic Desdouits, CEO of Orano Med, as well as the company’s partners, key stakeholders, and official representatives.

Hayward Holdings, Inc. (NYSE: HAYW) (“Hayward” or the “Company”), a leading global pool and outdoor living technology company, today announced the appointment of Jared Arrowood as Vice President and Chief Accounting Officer, effective immediately. As principal accounting officer, Arrowood will oversee the Company’s global financial reporting, tax, operational finance and technical accounting functions.

Supernal, which builds AI operating systems for midsize businesses, today announced that its AI-assisted science-fiction project, The Thorne Protocol, took third place in the Future Vision XPRIZE, a global competition exploring how technology can help create a future worth building. The Thorne Protocol also took third place in the separate SPECS Audience Choice Award, determined entirely by public voting among the competition’s 65 official selections.

BlueWind Medical, developer of the Revi® System for urgency urinary incontinence (UUI), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved a new Category I CPT code for subfascial implantation of a tibial neuromodulation device. The new code takes effect January 1, 2028.

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2026 on Wednesday, November 4, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 4, 2026.

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine.

Blade Urban Air Mobility, Inc. (“Blade”), a Joby Aviation company, today announced the return of BLADEone, its jet service between New York and South Florida, in partnership with Aero, the Los Angeles-based private jet airline. The seasonal jet service is expected to run from Thursday, November 19, 2026 through Sunday, May 2, 2027, with flights between Westchester County Airport (HPN) and Palm Beach’s President Donald J. Trump International Airport (DJT) or Miami-Opa Locka Executive Airport (OPF).

GridCARE today announced that it is working with Southern California Edison (SCE) to explore physics-based AI technology to identify additional capacity that could support new customer connections on otherwise constrained parts of its grid. GridCARE's Power Acceleration may help bring customers online sooner, maintain reliability and improve affordability by getting more capacity from existing assets.

SimpleClosure, the industry standard for responsible company shutdowns, today announced a partnership with Intuit, the global financial technology platform that makes TurboTax, Credit Karma, QuickBooks, Mailchimp, Intuit Enterprise Suite, and Intuit Accountant Suite, to help QuickBooks Workforce customers properly close state payroll tax accounts when they stop running payroll. For customers who are shutting down their business entirely, the partnership also provides easy access to SimpleClosure dissolution services, which includes handling the 95+ moving parts of a shutdown.

InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, today announced that Richard Rogoff, President & CEO, and Duncan Gilmour, Chief Financial Officer, will participate in the 18th Annual CEO Investor Summit on Tuesday, October 13, 2026, at the St. Regis Hotel in San Francisco, California.

Sole Source Capital LLC (“SSC”), an industrial and business services-focused private equity firm, today announced the appointment of Claire Bissot, SPHR, as Chief Human Resources Officer (CHRO), a newly created role focused on strengthening human capital and organizational capabilities across the firm and its portfolio companies.

Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2026 financial results prior to market open on Tuesday, November 3, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.

Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2026 results before the market opens on Thursday, October 29, 2026, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).

Druva, the resilience foundation for the AI enterprise, today announced the winners and honorees of its 2026 Druva North Star Awards, recognizing customers demonstrating leadership and impact across AI, cyber resilience, and cloud-native transformation.

BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements and proven fitness programs that help people take control of their health inside and out, today announced the launch of P90X Energy Drinks, a new zero sugar, ready-to-drink beverage designed to support energy, focus and performance.

Regulatory News:

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced data from a new molecular profiling and tumor biomarker analysis of the Phase 2 RAMP 201 clinical trial of avutometinib plus defactinib in patients with recurrent low-grade serous ovarian cancer (LGSOC), as well as a new external control arm analysis comparing outcomes from RAMP 201 with conventional care. The analyses will be presented today at the International Gynecologic Cancer Society (IGCS) 2026 Annual Global Meeting in Montréal, Canada, October 1-3, 2026. Encore data from the Phase 2 RAMP 201J study in Japanese patients are also being featured in a rapid oral presentation.

BNB Plus Corp. (OTCQB: BNBX) ("BNBX" or the "Company") today announced that the Company will transition from its current strategy as a digital asset treasury company focused exclusively on the BNB Chain ecosystem into an operating company focused on the deployment of infrastructure necessary for financial institutions and enterprises to adopt, operate, and utilize emerging open network technologies, including blockchain and agentic AI.

NETSTREIT Corp. (NYSE: NTST) (the “Company”) announced the closing of $550.0 million in additional financing commitments and amendments to its existing credit facilities agented by PNC Bank, National Association (the “PNC Credit Agreement”), Wells Fargo Bank, National Association (the “Wells Fargo Credit Agreement”) and Truist Bank (the “Truist Credit Agreement”).

ACCO Brands Corporation (NYSE: ACCO), a global leader in branded office and learning products and technology accessories, today announced it has successfully completed its previously announced acquisition of Trust. Trust designs and markets a comprehensive range of PC accessories, gaming, smart home and mobile peripherals, sold through leading retailers, e-commerce platforms, and B2B channels across Europe and Latin America.

Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a leading global provider of satellite data, analytics and intelligence, today announced the successful launch of the first three satellites built at its manufacturing facility in Boulder, Colorado. Launched aboard SpaceX’s Transporter-18 rideshare mission, the satellites mark an operational milestone in expanding Spire’s U.S. manufacturing footprint to meet growing national security demand.

NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced new AI and automation capabilities for NIQ Spaceman®, its retail space planning and merchandising platform trusted by more than 600 retailers across 65+ countries. The enhancements help retailers create store-specific planograms up to 50 times faster, identify execution and compliance gaps, and scale merchandising decisions across their store networks through expanded cloud-based access.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to one senior leader and ten newly hired non-executive employees. The equity awards for the senior leader were granted on September 30, 2026 and consisted of options to purchase an aggregate of 121,800 shares and restricted share units covering an aggregate of 58,000 shares. The options have an exercise price per share equal to $12.44. The equity awards to the ten newly hired non-executive employees were granted on October 1, 2026 and consisted of options to purchase an aggregate of 97,100 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 46,200 shares. These options have an exercise price per share equal to $11.95, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date. The options will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted share units and nominal cost options will vest in four equal annual installments, subject to each employee’s continued employment.

Global leaders across healthcare, science, technology, policy, and investment will convene at the Abu Dhabi Future Health Summit from 20 to 22 October 2026 to examine how health systems can better anticipate risk and enable earlier intervention as advances in AI, genomics, diagnostics, and health data create new possibilities for understanding health risks earlier.

GuidePoint Security, a cybersecurity advisor organizations rely on to protect what matters most, today announced that it has joined Amazon Web Services (AWS) Security Hub Extended as a services partner. GuidePoint brings advisory and implementation expertise to help organizations navigate, deploy and optimize the AWS and third-party security technologies available through AWS Security Hub Extended.

Banc of California, Inc. (the “Company”) (NYSE: BANC) today announced it will release financial results for the third quarter ended September 30, 2026 after market close on Tuesday, October 27, 2026. The Company will host a conference call to discuss these financial results the following day on Wednesday, October 28, 2026, at 8:30 a.m. Pacific Time (PT).

LimaCharlie and Varist have forged an alliance to bring real-time AI-scale detection of known and unknown malware threats to customers via the LimaCharlie Marketplace. Managed security service providers (MSSPs) and enterprises that use the LimaCharlie Agentic SecOps Workspace to build their security stacks can integrate Varist’s Hybrid Detection Engine™ as an extension and begin scanning and analyzing malware threats within minutes.

Optimum, a leading provider of fiber internet, mobile and TV services, today announced the launch of its new fiber network in Abbeville, bringing residents and businesses access to internet speeds of up to 8 Gbps and making a $10,000 investment in four local schools: James A. Herod Elementary, Eaton Park Elementary, J.H. Williams Middle School, and Abbeville High School.

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Dr. Jonathan Alis, Dr. Seth I. Sokol and their team at Jacobi Hospital in Bronx, New York have been selected as an ALPHA-PE Research Fund award recipients. The independent, investigator-led study, supported in partnership with The PERT Consortium®, will evaluate CT pulmonary angiography radiomics as predictors of thrombus biology, thrombectomy success and long-term outcomes in patients with pulmonary embolism (PE).

CareTrust REIT, Inc. (NYSE:CTRE) (“CareTrust” or the “Company”) announced today that it has entered into a definitive agreement with LNT Care Developments Holdings Limited (“LNT”), a prolific United Kingdom-based care home developer and operator, to acquire 45 new care homes for approximately £1.1 billion in a strategic transaction for the Company that secures a pathway to building a significant senior housing operating portfolio (“SHOP”) platform across the U.K.

Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial collaboration agreement with Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) to evaluate ivonescimab, a novel, potential first-in-class investigational PD-1 / VEGF bispecific antibody, in combination with Datroway® (datopotamab deruxtecan), a TROP2-directed antibody drug conjugate (ADC), across multiple solid tumor settings, intending to include breast and lung cancer. The companies intend to begin with a Phase III trial in first-line triple-negative breast cancer (TNBC).

Italfarmaco S.p.A. (“Italfarmaco”) and JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) today announced an exclusive license agreement to develop and commercialize JR-141 in the United States, Europe, and Latin America (“licensed territories”) upon regulatory approval. JR-141 is a blood-brain barrier (BBB) penetrating enzyme replacement therapy currently in Phase III (NCT04573023) evaluation as a treatment of Hunter syndrome (also known as mucopolysaccharidosis type II or MPS II). Approved and launched in Japan in 2021 as IZCARGO™ (INN: pabinafusp alfa), JCR and Italfarmaco seek to obtain regulatory approval for JR-141 from the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the U.K. Medicines and Healthcare products Regulatory Agency (MHRA), and the Brazilian Health Regulatory Agency (ANVISA).

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics Inc. (Nasdaq: SMMT) to evaluate Datroway® (datopotamab deruxtecan) in combination with ivonescimab across multiple tumor types including lung and breast cancers. The companies intend to begin with a phase 3 trial in first-line triple negative breast cancer (TNBC).

Kyocera Corporation (President and CEO: Shiro Sakushima, hereafter "Kyocera") today announced plans to begin sales in November 2026 of a new circulating inkjet printhead for label and packaging printing. The printhead supports white ink, varnish ink*1, and foil decoration*2. By accommodating a wider range of ink viscosities and enabling high-speed printing, this product addresses the increasing demand for diverse decorative effects in the label and packaging market.

Blockworks’ Digital Asset Summit (DAS) Asia arrives in Singapore for its first edition this Oct 7th alongside TOKEN2049, convening the leaders shaping the future of digital assets. Hosted at the Marina Bay Sands Convention Center, the summit will bring together top institutional voices to examine how digital assets, evolving onchain market dynamics and breakthrough partnerships & innovations are transforming the global financial landscape.